Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cell Reports|August 29, 2024
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responsesIda Paciello, Giulio Pierleoni, Elisa Pantano, et al.Diagnostics (Basel, Switzerland)|August 23, 2020
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 OutbreakGianluca Sambataro, Mauro Giuffrè, Domenico Sambataro, et al.Nature Communications|January 4, 2023
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody responseEmanuele Andreano, Ida Paciello, Giulio Pierleoni, et al.Jac-Antimicrobial Resistance|March 10, 2022
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing <i>Klebsiella pneumoniae</i>: a multicentre studyMario Tumbarello, Francesca Raffaelli, Antonio Cascio, et al.Science Translational Medicine|December 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153Ida Paciello, Emily J Rundlet, Ling Zhou, et al.Plos One|February 21, 2018
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patientsLucia Taramasso, Antonio Di Biagio, Francesca Bovis, et al.Autophagy|December 29, 2021
The polymorphism L412F in <i>TLR3</i> inhibits autophagy and is a marker of severe COVID-19 in malesSusanna Croci, Mary Anna Venneri, Stefania Mantovani, et al.Cell|March 5, 2021
Extremely potent human monoclonal antibodies from COVID-19 convalescent patientsEmanuele Andreano, Emanuele Nicastri, Ida Paciello, et al.Viruses|February 28, 2023
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)Tommaso Manciulli, Michele Spinicci, Barbara Rossetti, et al.Open Forum Infectious Diseases|June 10, 2024
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter StudyMario Tumbarello, Francesca Raffaelli, Maddalena Giannella, et al.Pageof 8